These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes. Liu SD, Su J, Zhang SM, Dong HP, Wang H, Luo W, Wen Q, He JC, Yang XF, Ma L. J Cell Mol Med; 2016 Sep; 20(9):1718-28. PubMed ID: 27072810 [Abstract] [Full Text] [Related]
3. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. Joosten SA, van Meijgaarden KE, van Weeren PC, Kazi F, Geluk A, Savage ND, Drijfhout JW, Flower DR, Hanekom WA, Klein MR, Ottenhoff TH. PLoS Pathog; 2010 Feb 26; 6(2):e1000782. PubMed ID: 20195504 [Abstract] [Full Text] [Related]
5. MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection. Bian Y, Shang S, Siddiqui S, Zhao J, Joosten SA, Ottenhoff THM, Cantor H, Wang CR. PLoS Pathog; 2017 May 26; 13(5):e1006384. PubMed ID: 28475642 [Abstract] [Full Text] [Related]
7. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis. Singh M, Bhatt P, Sharma M, Varma-Basil M, Chaudhry A, Sharma S. Infect Genet Evol; 2019 Oct 26; 74():103930. PubMed ID: 31228643 [Abstract] [Full Text] [Related]
12. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis. Rai PK, Chodisetti SB, Maurya SK, Nadeem S, Zeng W, Janmeja AK, Jackson DC, Agrewala JN. J Transl Med; 2018 Oct 11; 16(1):279. PubMed ID: 30305097 [Abstract] [Full Text] [Related]
13. Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis. Li D, Dou Z, Wu Y, Qi Y, Chen J, Gao Y. Protein Pept Lett; 2020 Oct 11; 27(11):1141-1150. PubMed ID: 32370703 [Abstract] [Full Text] [Related]
15. An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection. Cayabyab MJ, Qin L, Kashino SS, Izzo A, Campos-Neto A. Vaccine; 2013 Oct 01; 31(42):4834-40. PubMed ID: 23933335 [Abstract] [Full Text] [Related]
16. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis. Fonseca DP, Joosten D, Snippe H, Verheul AF. Mol Immunol; 2000 Jun 01; 37(8):413-22. PubMed ID: 11090876 [Abstract] [Full Text] [Related]
17. Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo. Woodworth JS, Wu Y, Behar SM. J Immunol; 2008 Dec 15; 181(12):8595-603. PubMed ID: 19050279 [Abstract] [Full Text] [Related]
18. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein. Fonseca DP, Benaissa-Trouw B, van Engelen M, Kraaijeveld CA, Snippe H, Verheul AF. Infect Immun; 2001 Aug 15; 69(8):4839-45. PubMed ID: 11447158 [Abstract] [Full Text] [Related]